International Journal of Stroke/journals.sagepub.com
Oct 3, 2026, 00:25
Antiplatelets May Be a Strong Option After Ischemic Stroke in Active Cancer – International Journal of Stroke
International Journal of Stroke shared a post on LinkedIn about a recent article by Gianluca Costamagna et al., adding:
“New data suggest antiplatelets may be a strong option after ischemic stroke in active cancer, with lower 3-month recurrence and mortality vs anticoagulation.”
Title: Clinical Outcomes among Patients with Active Cancer and Acute Ischemic Stroke Treated with Antiplatelet versus Anticoagulant Therapy.
Authors: Gianluca Costamagna, Andreas Hottinger, Francoise Livio, Babak Benjamin Navi, Davide Strambo, Patrik Michel
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 3, 2026, 00:24Mavis Agnes Kisakye: Honored to Join UNHLS Leadership in Advancing HIV Diagnostics in Uganda
-
Oct 3, 2026, 00:23Phil Spinella: Blood is for Bleeding, Salt Water is for Cooking pasta, Keeping it simple
-
Oct 3, 2026, 00:21Pablo Corral: The ANGPTL Axis in Dyslipidemia and Cardiovascular Risk
-
Oct 3, 2026, 00:20Raghavendra Rao: The Link Between Chronic Venous Disease and VTE May Be Less Robust Than Previously Thought
-
Oct 3, 2026, 00:19Nicolas Hubacz: Immune Cells in the Embryo
-
Oct 3, 2026, 00:18Kalpana Gupta Shekhawat: Reading Beyond the Numbers – A Deeper Look at Routine Blood Reports
-
Oct 3, 2026, 00:17Paulus Kirchhof: Aortic stiffness – A Consequence of High Blood Pressure, or a Driver, or Both?
-
Oct 3, 2026, 00:17Konstantin Yenkoyan: When Science Steps Outside the Laboratory – ERNA 2026
-
Oct 2, 2026, 18:34Kamini Khillan: Massive Transfusion Protocol for PPH Management